Bioreducible Gene Delivery Platform that Promotes Intracellular Payload Release and Widespread Brain Dispersion

Area of Science:

• Biomedical Engineering
• Neuroscience
• Polymer Science

Background:

• Intracranial gene therapy holds promise for neurological disorders.
• Current gene delivery methods face challenges in efficacy and specificity.
• Viral vectors have shown clinical success but can have limitations.

Purpose of the Study:

• To introduce a novel bioreducible polymer-based gene delivery platform.
• To evaluate the platform's efficacy for transgene expression in the brain.
• To compare the platform's performance against non-biodegradable nanoparticles and viral vectors.

Main Methods:

• Development of bioreducible polymer nanoparticles for gene delivery.
• In vitro and in vivo assessment of gene delivery efficacy.
• Intracranial convection-enhanced delivery in relevant brain models.
• Comparison with non-biodegradable nanoparticles and a clinically relevant viral vector.

Main Results:

• The bioreducible nanoparticles demonstrated enhanced gene delivery efficacy in vitro and in vivo.
• Preferential intracellular release of gene payloads contributed to improved efficacy.
• The platform showed competitive gene delivery in a neuron-rich brain region compared to a viral vector.
• Widespread transgene expression was achieved in multiple brain regions.

Conclusions:

• The novel bioreducible polymer platform is effective for intracranial gene delivery.
• This platform offers an attractive alternative to viral vectors for brain gene therapy.
• The technology has potential therapeutic applications for neurological disorders.